Serum osteocalcin (bone Gla-protein) following corticosteroid therapy in postmenopausal women with rheumatoid arthritis. Comparison of the effect of prednisone and deflazacort

Carlomaurizio Montecucco(University of Pavia), P Fratino(University of Pavia), Fabio Baldi(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Enrico Luigi Chérié-Lignière(University of Pavia), Roberto Caporali(University of Milan), Anna Belloni Fortina(University of Padua), G. Tomassini(Ospedale Maggiore)
Clinical Rheumatology
September 1, 1988
10.1007/bf02239194
Cited by 21

Related Papers

Cigarette Smoking, Body Mass Index, and Stressful Life Events as Risk Factors for Psoriasis: Results from an Italian Case–Control Study
|Journal of Investigative Dermatology|2005|644
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial
|The Lancet|2021|315
Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial
|Nature Medicine|2022|277
Chilblain‐like lesions during COVID‐19 epidemic: a preliminary study on 63 patients
|Journal of the European Academy of Dermatology and Venereology|2020|248
Methotrexate treatment in juvenile localized scleroderma: A randomized, double-blind, placebo-controlled trial
|Arthritis & Rheumatism|2011|216